Getting monkeypox treatment is easier, but still daunting and confusing
Though doctors and advocates have helped speed up access to the antiviral pills – of which the U.S. has enough to treat 1.7 million people – health providers are few and forms are still required.
When Kyle Planck got monkeypox, he was in the worst pain of his life. "I was at a seven or eight [out of 10] of the worst pain I could ever imagine, and it came and went throughout the day," he says, "especially because it was an internal sort of pain – it was very hard to deal with."
In early July, the infectious diseases graduate student in New York City had pustules in different stages on his body. He spent several days bedridden. Then Planck got access to tecovirimat – brand name TPOXX – a two-week course
